104 related articles for article (PubMed ID: 1244078)
21. [Tryptophan metabolism in patients with vitiligo].
Costa C; Cardin EL; De Antoni A; Vanzan S; Allegri G
Boll Soc Ital Biol Sper; 1981 Oct; 57(19):1933-9. PubMed ID: 7317187
[TBL] [Abstract][Full Text] [Related]
22. [Combined enzymatic method for the determination of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in free and esterified form in the urine].
Schievelbein H; Löschenkohl K
Z Klin Chem Klin Biochem; 1968 May; 6(3):138-41. PubMed ID: 5709551
[No Abstract] [Full Text] [Related]
23. Urinary excretion of 3-hydroxyanthranilic acid in neoplastic diseases and its biological effects.
Quagliariello E; Alifano A; Papa S
Acta Vitaminol; 1965 Dec; 19(5):169-78. PubMed ID: 5899056
[No Abstract] [Full Text] [Related]
24. The correlation between certain tryptophan metabolites and the N-nitrosamine content in the urine of bilharzial bladder cancer patients.
Abdel-Tawab GA; Aboul-Azm T; Ebied SA; el-Toukhy MA; Abdel-Hamied HA; el-Kholy ZA; el-Sharaky AS
J Urol; 1986 Apr; 135(4):826-30. PubMed ID: 3083120
[TBL] [Abstract][Full Text] [Related]
25. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours.
Nyholm KK; Sjölin KE; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1975 Nov; 22(6):509-16. PubMed ID: 1225382
[TBL] [Abstract][Full Text] [Related]
26. The action of 3-hydroxyanthranilic acid and other tryptophan metabolites on stimulated human lymphocytes.
Teulings FA; Lems PH; Portengen H; Henkelman MS; Blonk DI
Acta Vitaminol Enzymol; 1975; 29(1-6):113-6. PubMed ID: 1244079
[TBL] [Abstract][Full Text] [Related]
27. [A tryptophan metabolic disorder in patients with kidney tumors].
Zhurkina OV
Urol Nefrol (Mosk); 1996; (4):14-7. PubMed ID: 8928340
[TBL] [Abstract][Full Text] [Related]
28. [Different effects of kynurenines on rat liver tryptophan pyrrolase activity].
Kiseleva IP; Lapin IP; Prakh'e IB; Samsonova ML
Vopr Med Khim; 1980; 26(4):458-61. PubMed ID: 7456383
[TBL] [Abstract][Full Text] [Related]
29. [3-Hydroxyanthranilic acid in the blood of patients with kidney tumors].
Korosteleva TA; Kliucharev BV; Belokhvostova AT
Vopr Onkol; 1976; 22(11):95-8. PubMed ID: 1014510
[TBL] [Abstract][Full Text] [Related]
30. [Epidermal growth factor in the urine of patients with renal cell carcinoma and bladder tumor].
Ishikura K; Hasegawa M; Nomura K; Okamoto T; Tanji S; Abe T; Fujioka T; Ohhori T; Kubo T
Hinyokika Kiyo; 1991 Oct; 37(10):1229-34. PubMed ID: 1755416
[TBL] [Abstract][Full Text] [Related]
31. Hydroxykynurenine/hydroxyanthranilic acid ratios and febrile convulsions.
McKiernan J; Mellor D; Court S; Edson J; Lacey K
Arch Dis Child; 1980 Nov; 55(11):873-5. PubMed ID: 7436459
[TBL] [Abstract][Full Text] [Related]
32. Studies on tryptophan metabolism in bilharzial bladder cancer patients.
Abdel-Tawab GA; Ibrahim EK; el-Masri A; al-Ghorab M; Makhyoun N
Invest Urol; 1968 May; 5(6):591-601. PubMed ID: 5743558
[No Abstract] [Full Text] [Related]
33. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
34. [Studies of tryptophan metabolism in cancer of the urinary bladder].
Wich H; Grimm U; Knapp A
Z Urol Nephrol; 1989 Nov; 82(11):593-6. PubMed ID: 2618183
[TBL] [Abstract][Full Text] [Related]
35. [3-HAA-antigen and immunoreactivity indices in patients with bladder tumors].
Korosteleva TA; Rabkova LM; Belokhvostova AT; Movsesian KS; Skadova VM
Vopr Onkol; 1986; 32(9):48-53. PubMed ID: 3765523
[TBL] [Abstract][Full Text] [Related]
36. Effect of phototherapy on the urinary excretion of tryptophan metabolites in neonatal hyperbilirubinemia.
De Antoni A; Rubaltelli FF; Costa C; Allegri G
Acta Vitaminol Enzymol; 1975; 29(1-6):145-50. PubMed ID: 1244083
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
38. [Immunological reaction to 3-hydroxyanthranilic acid in the diagnosis of lung cancer].
Kolesnikov IS; Lytkin MI; Korosteleva TA; Shalaev SA; Belokhvostova AT
Vestn Khir Im I I Grek; 1981 Apr; 126(4):3-7. PubMed ID: 6791347
[TBL] [Abstract][Full Text] [Related]
39. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
[TBL] [Abstract][Full Text] [Related]
40. [Microanalysis of tryptophan metabolites].
Watanabe M
Yakugaku Zasshi; 1997 Nov; 117(10-11):657-64. PubMed ID: 9414579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
